Hemostatic abnormalities associated with cancer and its therapy

Annals of Clinical and Laboratory Science

Volumn 27, Issue 6, 1997, Pages 391-395

  Glassman, Armand B ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRINOPEPTIDE A; PROTEIN C;

ARTICLE; BLEEDING TENDENCY; CANCER; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; VEIN THROMBOSIS;

ANTINEOPLASTIC AGENTS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; HEMORRHAGE; HEMOSTASIS; HUMANS; NEOPLASMS; RADIOTHERAPY;

EID: 0031464197     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992;11:237-48.
2. Bick RL. Coagulation abnormalities in malignancy. Semin Thromb Hemost 1992;18:352-72.
3. Glaspy JA. Disturbances in hemostasis in patients with B-cell malignancies. Semin Thromb Hemostat 1992; 18:440-8.
4. Wehmeier A, Daum I, Jamin H, et al. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. Ann Hematol 1991;63:201-6.
5. Glassman AB. Thrombosis and coagulation abnormalities associated with cancer. Ann Clin Lab Sci 1994;24:1-5.
6. Wehmeier A, Fricke S, Scharf RE, et al. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders. Eur J Haematol 1990;45:191-7.
7. Kunkel LA. Acquired circulating anticoagulants in malignancy. Semin Thromb Hemost 1992;18:416-23.
8. 506 to Gln mutation in the factor V gene, and venous thrombosis. Thromb Haemost 1995;73:739-42.
9. Jakway JL. Acquired von Willebrand's disease in malignancy. Semin Thromb Hemost 1992;18:438-9.
10. Goodnough LT, Saito H, Manni A, et al. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. Cancer 1984;54:1264-9.
11. Jensen R, Ens G. Chemotherapy and hemostasis. Clin Hemost Rev 1992;16:1-3.
12. Weiss RB, Tormey DC, Holland JF, et al. Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rev 1991;65:677-82.
13. Scates SM. Diagnosis and treatment of cancer related thrombosis. Semin Thromb Hemost 1992;18:373-9.
14. Sarris AH, Estey E, McCarron S, et al. The coagulopathy of acute promyelocytic leukemia: Universal thrombin activation detected by serial D-Dimer and F1.2 Determinations. Blood (Suppl) 1995;86:778a, #3098, Abstract.
15. Gadducci A, Baicchi V, del Bravo B. The assessment of the hemostasis system in patients with ovarian and cervical carcinoma. Cancer Journal 1991;4:183-7.